
Exclusive: Merck explores $15 billion-plus drug portfolio sale
NEW YORK/LONDON (Reuters) - Merck & Co Inc is considering selling a big portfolio of mature drugs that could fetch more than $15 billion, according to people familiar with the...
eNewspaper
Trending:









